Literature DB >> 12852838

Role of endogenous peroxynitrite in pulmonary injury and fibrosis induced by bleomycin A5 in rats.

Xiao-Ling Chen1, Wen-Bin Li, Ai-Min Zhou, Jie Ai, Shan-Sheng Huang.   

Abstract

AIM: To observe the role of endogenous peroxynitrite (ONOO-) in pulmonary injury and fibrosis induced by bleomycin A5 (BLM-A5) in rats.
METHODS: Pulmonary injury and fibrosis of rats were evaluated by testing the level of lipid peroxides (LPO) in out-going pulmonary blood (OPB), and by observing histological changes, including type III and type I collagen changes in lung which were examined with Sirius red staining under polarized light. The peroxynitrite expression was detected by immunohistochemistry for nitrotyrosine (NT), a marker of the peroxynitrite production.
RESULTS: (1) The level of LPO was elevated in OPB of rats on d 14 after intratracheal administration of BLM-A5. Thickened alveolar wall and macrophage infiltration were seen, and fibroblasts were near by the interstitial macrophages. Increased amounts of type III collagen and type I collagen were deposited in disoriented fashion. (2) High expression of ONOO- was detected in alveolar epithelial cells and pulmonary interstitial macrophages. (3) The above changes were reduced by aminoguanidine (AG), an inhibitor of nitric oxide synthase (iNOS).
CONCLUSION: Endogenous ONOO- mediated BLM-A5-induced pulmonary toxicity. The therapeutic potential of AG for pulmonary injury and fibrosis was realized partly by reducing ONOO- formation.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12852838

Source DB:  PubMed          Journal:  Acta Pharmacol Sin        ISSN: 1671-4083            Impact factor:   6.150


  6 in total

1.  Protective and therapeutic effect of molsidomine on bleomycin-induced lung fibrosis in rats.

Authors:  Talat Kilic; Hakan Parlakpinar; Alaadin Polat; Elif Taslidere; Nigar Vardi; Ediz Sarihan; Hilal Ermis; Kevser Tanbag
Journal:  Inflammation       Date:  2014-08       Impact factor: 4.092

2.  Nitric oxide mediates bleomycin-induced angiogenesis and pulmonary fibrosis via regulation of VEGF.

Authors:  Anand Krishnan V Iyer; Vani Ramesh; Carlos A Castro; Vivek Kaushik; Yogesh M Kulkarni; Clayton A Wright; Rajkumar Venkatadri; Yon Rojanasakul; Neelam Azad
Journal:  J Cell Biochem       Date:  2015-11       Impact factor: 4.429

Review 3.  The bleomycin animal model: a useful tool to investigate treatment options for idiopathic pulmonary fibrosis?

Authors:  Antje Moeller; Kjetil Ask; David Warburton; Jack Gauldie; Martin Kolb
Journal:  Int J Biochem Cell Biol       Date:  2007-08-30       Impact factor: 5.085

4.  Inhibition or knock out of inducible nitric oxide synthase result in resistance to bleomycin-induced lung injury.

Authors:  Tiziana Genovese; Salvatore Cuzzocrea; Rosanna Di Paola; Marco Failla; Emanuela Mazzon; Maria Angela Sortino; Giuseppina Frasca; Elisa Gili; Nunzio Crimi; Achille P Caputi; Carlo Vancheri
Journal:  Respir Res       Date:  2005-06-14

Review 5.  Modulation of Radiation Response by the Tetrahydrobiopterin Pathway.

Authors:  Rupak Pathak; Amrita K Cheema; Simina M Boca; Kimberly J Krager; Martin Hauer-Jensen; Nukhet Aykin-Burns
Journal:  Antioxidants (Basel)       Date:  2015-01-22

6.  Amifostine Analog, DRDE-30, Attenuates Bleomycin-Induced Pulmonary Fibrosis in Mice.

Authors:  Aastha Arora; Vikas Bhuria; Puja P Hazari; Uma Pathak; Sweta Mathur; Bal G Roy; Rajat Sandhir; Ravi Soni; Bilikere S Dwarakanath; Anant N Bhatt
Journal:  Front Pharmacol       Date:  2018-04-24       Impact factor: 5.810

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.